Equities
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)45.25
  • Today's Change0.35 / 0.78%
  • Shares traded7.02k
  • 1 Year change+21.80%
  • Beta--
Data delayed at least 15 minutes, as of Nov 25 2024 16:29 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of EUR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments107333217
Total Receivables, Net306222199
Total Inventory362316265
Prepaid expenses508.609.70
Other current assets, total0.600.200.10
Total current assets825879690
Property, plant & equipment, net401373333
Goodwill, net878714
Intangibles, net11310456
Long term investments0.300.300.30
Note receivable - long term0.901.100.20
Other long term assets(0.1)(0.1)0
Total assets1,4391,5041,114
LIABILITIES
Accounts payable10211490
Accrued expenses8210674
Notes payable/short-term debt000
Current portion long-term debt/capital leases29173.80
Other current liabilities, total523842
Total current liabilities265275209
Total long term debt171197105
Total debt200214109
Deferred income tax324234
Minority interest------
Other liabilities, total818118
Total liabilities549596366
SHAREHOLDERS EQUITY
Common stock929292
Additional paid-in capital------
Retained earnings (accumulated deficit)808824682
Treasury stock - common--(35)(18)
Unrealized gain (loss)------
Other equity, total(9.6)26(8.3)
Total equity890908748
Total liabilities & shareholders' equity1,4391,5041,114
Total common shares outstanding140140141
Treasury shares - common primary issue0.780.930.57
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.